AlphaCentric Advisors LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 196 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.

Quarter-by-quarter ownership
AlphaCentric Advisors LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$388,500
-19.7%
50,0000.0%0.22%
-18.2%
Q2 2023$484,000
-43.0%
50,000
-35.5%
0.27%
-54.1%
Q1 2023$849,400
-44.2%
77,500
-78.0%
0.59%
-61.1%
Q4 2022$1,522,800
+27.0%
352,500
+121.0%
1.50%
+22.4%
Q3 2022$1,199,000
+270.1%
159,500
+538.0%
1.23%
+1297.7%
Q2 2021$324,000
-28.6%
25,000
-28.6%
0.09%
-42.5%
Q1 2021$454,000
+63.9%
35,000
+75.0%
0.15%
+31.9%
Q4 2020$277,000
+361.7%
20,000
+387.8%
0.12%
+300.0%
Q3 2020$60,0004,1000.03%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 503,248$6,535,00010.30%
Prosight Management, LP 360,834$4,685,0003.84%
Healthcare Value Capital, LLC 100,000$1,299,0002.89%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,748,208$22,700,0002.32%
DG Capital Management, LLC 591,154$7,676,0001.83%
NEA Management Company, LLC 5,172,683$67,193,0001.51%
Altium Capital Management LP 408,908$5,310,0001.47%
IRONWOOD INVESTMENT MANAGEMENT LLC 170,316$2,212,0001.17%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 298,500$3,875,0001.02%
KNOTT DAVID M 154,840$2,011,0000.86%
View complete list of AURINIA PHARMACEUTICALS INC shareholders